Atlas Trials

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

Clinical trial NCT03379909 · RECRUITING

Trial details

NCT number
NCT03379909
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Superficial Bladder CancerBladder Cancer
Start date
2019-09-01
Primary completion
2024-07-31
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.